You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
30 April 2024
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report
23 April 2024
Xlife Sciences AG Publishes 2023 Annual Report
29 December 2023
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
18 December 2023
Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration
18 October 2023
Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million
21 September 2023
Xlife Sciences with significant progress in H1 2023